Subscribe for great stories in your community!
The Horsham site of a former mail order pharmacy is being redesigned as the Center for Diagnostic Discovery, an entrepreneurial environment for healthcare innovation. John…
Merck — the North Jersey-centric big pharma firm with significant Montco outposts in West Point and Lansdale — has entered into a purchase agreement to acquire…
The Food and Drug Administration has awarded King of Prussia-based CSL Behring marketing approval for Hemgenix, the first hemophilia B gene therapy to treat…
Plymouth Meeting pharmaceutical company Inovio has discontinued development of two vaccines, based on evidence of their ineffectiveness. As a result, its stock prices showed a…
Merck & Co. has raised its revenue outlook, based on a notable rise in sales for 3Q2022. Sabela Ojea reported the revised projections in the…
After 13 years without an outside investment, Abington-based ZenQMS brought on Susquehanna Growth Equity as a minority investment partner in August to help with…
K. Barry Sharpless, a graduate of Friends’ Central School in Wynnewood, won his second Nobel Prize in chemistry this week, writes Tom Avril for The…
Big Pharma company GSK — which has a multi-site presence in Montgomery County (King of Prussia, Conshohocken, and Collegeville) — has announced its first female CFO…
Alladapt of Menlo Park, Calif., is investing $30 million to expand its operations to a manufacturing plant in Hatfield. The biopharmaceutical company specializes in developing…
Allergensis, a Hatfield-based manufacturer, is marketing tests that it states are predictively accurate in diagnosing peanut allergies, providing more reliable results of traditional skin…
Montgomery County will receive part of the more than $1 billion settlement between Pa. and three major pharmaceutical distributors regarding their roles in creating and…
CurveBeam AI, a Hatfield medical imaging technology developer, has signed a merger deal with StraxCorp, Melbourne, Australia. John George covered the intercontinental collaboration for the…
Almac Group is planning a major expansion to its North American headquarters in Souderton that will considerably increase the company’s capacity for manufacturing, packaging…
Tavanta Therapeutics, King of Prussia, has reached phase three of clinical trials associated with TAVT-45, a pipeline of specialty drugs to treat prostate cancer…
Exelixis Inc., a Calif. biotech company, targeted King of Prussia to hold its East Coast operations. However, absent a building it found suitable, it is…
Angle, a U.K.-housed biotech firm with its U.S. H.Q. in Plymouth Meeting, is setting to increase its workforce here by more…
Before we send you to this site, please subscribe to our daily newsletter.